US Food and Drug Administration warning letters are not always enough to compel improvements, and legal action may eventually follow, like it did for a manufacturing facility in Illinois that became a talking point for FDA compliance officials at recent conferences.
The denouement for the facility, and the string of FDA compliance actions and sometimes baffling company failure to respond, was...